Redefining type 2 diabetes: 'Diabesity' or 'obesity dependent diabetes mellitus'?

Obesity Reviews

Volumn 1, Issue 2, 2000, Pages 57-59

  Astrup, A ^a   Finer, N ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b LUTON AND DUNSTABLE HOSPITAL   (United Kingdom)

Author keywords

Obesity; Overweight; Type 2 diabetes

Indexed keywords

ADIPOSE TISSUE; BODY COMPOSITION; BODY MASS; DIABETES MELLITUS; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; REVIEW;

ADIPOSE TISSUE; BODY COMPOSITION; BODY MASS INDEX; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; HUMANS; OBESITY;

EID: 0034289882     PISSN: 14677881     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1467-789x.2000.00013.x     Document Type: Short Survey

References (15)

1. Report of a WHO study group. WHO Technical Report Series, no. 844. Prevention of diabetes mellitus. WHO Publications: Geneva, 1994.
2. Report of a WHO Consultation on Obesity, Geneva 3-5 June 1997. Obesity: preventing and managing the global epidemic. WHO Publications: Geneva, 1997.
3. Han TS, Richmond P, Avenell A, Lean MEJ. Waist circumference reduction and cardiovascular benefits during weight loss in women. Int J Obesity 1997; 21: 127-134.
4. Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995; 122: 481-486.
5. King H, Aubert RE, Herman WH. Global burden of diabetes 1995-2025. Diabetes Care 1998; 21: 1414-1431.
6. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes: UKPDS 33. UK Prospective Diabetes Study Group. Lancet 1998; 352: 837-853.
7. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-713.
8. Turner RC, Holman RR, Stratton IM, Cull CA, Matthews DR, Manley SE, Frighi V, Wright D, Neil A, Kohner E, McElroy H, Fox C, Hadden D. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes: UKPDS 34. UK Prospective Diabetes Study Group. Lancet 1998; 352: 854-865.
9. Olsson J, Lindberg G, Gottsäter M, Lindwall K, Sjöstrand Å, Tisell A, Melander A. Increased mortality in type 2 diabetic patients using sulphonylurea and metformin in combination: a population-based observational study. Diabetologia 2000; 43: 558-560.
10. Lean ME, Powrie JK, Anderson AS, Garthwaite PH. Obesity, weight loss and prognosis in type 2 diabetes. Diabetes Med 1990; 7: 228-233.
11. Williamson DF, Pamuk E, Thun M, Flanders D, Byers T, Health C. Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40-64. Am J Epidemiol 1995; 141: 1128-1141.
12. Pan X, Li G, Hu Y. Effect of dietary and/or exercise intervention on incidence of diabetes in 530 subjects with impaired glucose tolerance from 1986 to 1992. Chung Hua Nei Ko Tsa Chih. 1995; 34: 8-112.
13. Sjöström CD, Lissner L, Wedel H, Sjöström L. Reduction of incidence in diabetes, herpertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS intervention study. Obes Res 1999; 7: 477-484.
14. Sjöström L. Obesity, diabetes and other cardiovascular risk factors. Lessons from SOS. Int J Obes 2000; 24: S7.
15. Heymsfield SB, Segal KR, Hauptman J, Lucas CP, Boldrin MN, Rissanen A, Wilding JPH, Sjöström L. Effect of weight loss with Orlistat on glucose tolerance and progression to type 2 diabetes in obese adults. Arch Intern Med 2000; 160: 1321-1326.